AA
CTIC

Ancora Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Ancora Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed – – 2377
2021
Q2 		$0 Hold
1
– – ﹤0.01% 2194
2021
Q1 		$0 Hold
1
– – ﹤0.01% 1883
2020
Q4 		$0 Hold
1
– – ﹤0.01% 1595
2020
Q3 		$0 Hold
1
– – ﹤0.01% 1505
2020
Q2 		$0 Hold
1
– – ﹤0.01% 1529
2020
Q1 		$0 Hold
1
– – ﹤0.01% 1563
2019
Q4 		$0 Buy
+1
New +$1 ﹤0.01% 1397
2018
Q4 		– Sell
-1
Closed – – 1359
2018
Q3 		$0 Buy
+1
New +$2 ﹤0.01% 1371
2014
Q2 		– Sell
-5,500
Closed -$187K – 525
2014
Q1 		$187K Buy
5,500
+4,100
+293% +$140K 0.03% 410
2013
Q4 		$27K Buy
+1,400
New +$25.5K ﹤0.01% 421

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Ancora Advisors's CTIC Position: Q3 2021 in Review

Ancora Advisors sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2021, closing a stake of 1 share.

Ancora Advisors first reported a position in CTIC in Q4 2013 and held it in 10 quarters. The position peaked at $187K in Q1 2014. 56 funds tracked by Wall St. Rank hold CTIC as of Q3 2021.

  • Ancora Advisors reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2021 after selling out during the quarter.
  • Ancora Advisors sold 1 CTI BioPharma Corp. (DE) Common Stock share in Q3 2021.
  • Ancora Advisors first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2013 and held it in 10 quarters.
  • Ancora Advisors's CTI BioPharma Corp. (DE) Common Stock position peaked at $187K in Q1 2014.
  • 56 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2021.

Based on Ancora Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.